Compare abrdn Income Credit Strategies Fund (ACP) vs DexCom, Inc. (DXCM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
abrdn Income Credit Strategies Fund vs DexCom, Inc. — how do they compare? abrdn Income Credit Strategies Fund trades at $5.11 (market cap $641.16M), while DexCom, Inc. trades at $89.2 (market cap $33.79B). The key difference: DexCom, Inc. is far larger — about 52.7× abrdn Income Credit Strategies Fund's market cap, and abrdn Income Credit Strategies Fund pays a 18.2% dividend while DexCom, Inc. pays none. Which is the better fit depends on your goals.
| ACP | DXCM | |
|---|---|---|
Market Cap | $641.16M | $33.79B |
Sector | Financials | Health |
52-Week High | $5.98 | $89.53 |
52-Week Low | $5.01 | $54.84 |
Dividend Yield | 18.2% | — |
Enterprise Value | — | $33.24B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About abrdn Income Credit Strategies Fund
abrdn Income Credit Strategies Fund is a diversified, closed-end investment management company. Its primary goal is to generate high current income, with capital appreciation as a secondary objective. The fund mainly invests in debt and loan instruments from issuers across various industries and regions.
Read more on ACP →About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →
